Decline of Ves v 5‐specific blocking capacity in wasp venom‐allergic patients after stopping allergen immunotherapy

By  

ALLERGY, Vol. 70, Iss. 6, 2015-06 ,pp. : 715-719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of Folded Recombinant Der p 5, a Potential Diagnostic Marker Allergen for House Dust Mite Allergy

By  

International Archives of Allergy and Immunology, Vol. 147, Iss. 2, 2008-06 ,pp. : 101-109

Karger

Access to resources Recommend Favorite

Purification and Characterization of a Major Cross-Reactive Allergen from Epicoccum purpurascens

By  

International Archives of Allergy and Immunology, Vol. 133, Iss. 3, 2004-04 ,pp. : 217-224

Karger

Access to resources Recommend Favorite

Increased Level of Antibodies Cross-Reacting with Ves v 5 and CRISP-2 in MAR-Positive Patients

By  

International Archives of Allergy and Immunology, Vol. 160, Iss. 1, 2012-08 ,pp. : 47-55

Karger

Access to resources Recommend Favorite

Genetic Engineering of Recombinant Hypoallergenic Oligomers of the Major Birch Pollen Allergen, Bet v 1: Candidates for Specific Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 218-219

Karger

Access to resources Recommend Favorite